Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Epidiolex in pregnancy: new study tracks risks for moms and babies

NCT ID NCT06113237

First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 31 times

Summary

This study watches pregnant people who take the drug Epidiolex (used for seizures) to see if it causes any problems during pregnancy or for the baby up to one year old. Researchers will track birth defects, miscarriages, and other health issues. About 50 participants will join, and no new treatments are given—just observation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • United Biosource LLC

    RECRUITING

    Morgantown, West Virginia, 26508, United States

  • Vivantes Humboldt-Klinikum Klinik für Neurologie

    RECRUITING

    Berlin, 13509, Germany

Conditions

The condition(s) this trial relates to.

pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.